Zimbabwe: Drug-Resistant HIV Puts Strain On National Stocks

23 August 2017

Increased cases of drug resistant HIV are contributing to shortages of Abacavier, a drug given to HIV positive people, who would have failed or reacted to initial drug combinations, thereby exerting pressure on traditional stocks of the drug. Secretary for Health and Child Care Dr Gerald Gwinji said in an interview yesterday that the stock raptures of Abacavier could be because the number of people resistant to the HIV first line treatment had gone up.

Those who would have problems with the first line treatment are moved to the second line treatment which involves taking Abacavier.

...

AllAfrica publishes around 500 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.